Product
Onabotulinumtoxin-A
1 clinical trial
1 indication
Indication
MigraineClinical trial
An Exploratory, Prospective, Randomized, Pragmatic Open Label Cohort Study to Evaluate the Comparative Effectiveness of Eptinezumab in the United StatesStatus: Terminated, Estimated PCD: 2023-02-17